Cancer Research Horizons
Overview
Cancer Research Horizons is the innovation arm of Cancer Research UK, the world's largest charitable funder of cancer research. It acts as a venture philanthropy fund focused on bridging the gap between academic research and commercialization by investing in early-stage oncology opportunities. It supports the creation of spin-out companies, provides seed funding, and facilitates partnerships to develop new cancer treatments, diagnostics, and medical devices. All financial returns are reinvested into the fund and into further cancer research.
Portfolio Companies
6
Website
cancerresearchuk.orgInvestments
| Company | Date | Stage | Lead |
|---|---|---|---|
| BIOCAPTIVA LIMITED | Jun 2022 | Seed | Co-investor |
| Laigo Bio | Dec 2025 | Seed | Co-investor |
| 52North | Dec 2024 | Seed | Co-investor |
| Infinitopes Precision Immunomics | Jan 2026 | Seed | Co-investor |
| Mercy BioAnalytics | Apr 2023 | Series A | Co-investor |
For institutional investors. Book with your work email.
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
FAQ
Where is Cancer Research Horizons based?
Cancer Research Horizons is headquartered in London, England, United Kingdom.
When was Cancer Research Horizons founded?
Founding year information for Cancer Research Horizons is not publicly available.
How many portfolio companies does Cancer Research Horizons have?
Cancer Research Horizons has 6 portfolio companies in Caplight's dataset.
What are some companies in Cancer Research Horizons's portfolio?
Portfolio companies visible on Caplight include BIOCAPTIVA LIMITED, Laigo Bio, 52North, Infinitopes Precision Immunomics, Mercy BioAnalytics.
What was Cancer Research Horizons's most recent investment shown here?
Cancer Research Horizons's most recent investment in this portfolio sample was in Infinitopes Precision Immunomics in 2026.
What sectors does Cancer Research Horizons focus on?
Cancer Research Horizons focuses on Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Healthcare & Life Sciences, Frontier & Industrial Tech.
What company stages does Cancer Research Horizons focus on?
Cancer Research Horizons typically invests at the Early stage.
What is Cancer Research Horizons's AUM?
Cancer Research Horizons's assets under management are estimated between $37.5M and $37.5M.